Published on 30 Nov 2009
“ With IBM’s experience and technology, we’re positioning ourselves to gain new insights into how we can treat hereditary diseases. ”
Luca Sangiorgi, manager, Medical Genetics Unit, Rizzoli Orthopaedic Institute
Rizzoli Orthopaedic Institute
Rizzoli Orthopaedic Institute is a research hospital whose Medical Genetics Unit specializes in rare hereditary skeletal disease.
Italy’s Rizzoli Orthopaedic Institute sought stronger tools to study the genetic underpinnings of rare hereditary bone diseases.
Rizzoli engaged IBM Research to develop a first-of-a-kind pedigree analytics platform that integrates genomic data, medical images and family history into a powerful research tool.
More effective treatments for hereditary diseases through more targeted protocols; more accurate determination of hereditary disease risks; more informed basis for disease screening, enabling fewer unnecessary tests, thus reducing costs.
IBM products and services that were used in this case study.
Content Manager Enterprise Edition, InfoSphere Warehouse, Tivoli Directory Server, Tivoli Storage Manager, WebSphere Application Server
IBM Research, Service Oriented Architecture, Smarter Planet
© Copyright IBM Corporation 2009 <br /> <br /> IBM Corporation <br /> 1 New Orchard Road <br /> Armonk, NY 10504 <br /> U.S.A. <br /> <br /> Produced in the United States of America <br /> December 2009 <br /> All Rights Reserved. <br /> <br /> IBM, the IBM logo, ibm.com, Smarter Planet, the planet icon, InfoSphere, System x, Tivoli and WebSphere are trademarks of International Business Machines Corporation, registered in many jurisdictions worldwide. Other product and service names might be trademarks of IBM or other companies. A current list of IBM trademarks is available on the Web at ibm.com/legal/copytrade.shtml. <br /> <br /> This case study illustrates how one IBM customer uses IBM products. There is no guarantee of comparable results. <br /> <br /> References in this publication to IBM products or services do not imply that IBM intends to make them available in all countries in which IBM operates. <br /> <br /> ODC03152-USEN-00